carbonic anhydrase inhibitors (MetaSignal)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecarbonic anhydrase inhibitors (MetaSignal)
Drug Alias NameMST-100 seriesMST-200 seriesMST-300 series
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrase IX inhibitorsCarbonic anhydrase XII inhibitors
TargetsCarbonic anhydrase IXCarbonic anhydrase XII
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignalchem Lifesciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignalchem Lifesciences
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A